Cargando…

Nut consumption and incidence of seven cardiovascular diseases

BACKGROUND: Nut consumption has been found to be inversely associated with cardiovascular disease mortality, but the association between nut consumption and incidence of specific cardiovascular diseases is unclear. We examined the association between nut consumption and incidence of seven cardiovasc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Larsson, Susanna C, Drca, Nikola, Björck, Martin, Bäck, Magnus, Wolk, Alicja
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2018
Materias:	Cardiac Risk Factors and Prevention
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6161661/ https://www.ncbi.nlm.nih.gov/pubmed/29661934 http://dx.doi.org/10.1136/heartjnl-2017-312819

Ejemplares similares

Associations of egg consumption with cardiovascular disease in a cohort study of 0.5 million Chinese adults
por: Qin, Chenxi, et al.
Publicado: (2018)

Alcohol consumption and risk of incident heart failure in older men: a prospective cohort study
por: Wannamethee, S Goya, et al.
Publicado: (2015)

Association of social relationships with incident cardiovascular events and all-cause mortality
por: Gronewold, Janine, et al.
Publicado: (2020)

Incident cardiovascular events and imaging phenotypes in UK Biobank participants with past cancer
por: Raisi-Estabragh, Zahra, et al.
Publicado: (2023)

Low eosinophil and low lymphocyte counts and the incidence of 12 cardiovascular diseases: a CALIBER cohort study
por: Shah, Anoop Dinesh, et al.
Publicado: (2016)

Tea consumption and risk of ischaemic heart disease
por: Li, Xia, et al.
Publicado: (2017)

Incident cardiovascular, renal, metabolic diseases and death in individuals identified for risk-guided atrial fibrillation screening: a nationwide cohort study
por: Wu, Jianhua, et al.
Publicado: (2023)

Addition of cystatin C predicts cardiovascular death better than creatinine in intensive care
por: Helmersson-Karlqvist, Johanna, et al.
Publicado: (2022)

Impact of risk factors for major cardiovascular diseases: a comparison of life-time observational and Mendelian randomisation findings
por: Lind, Lars, et al.
Publicado: (2021)

Estimated 10-year cardiovascular mortality seriously underestimates overall cardiovascular risk
por: Jørstad, Harald T, et al.
Publicado: (2016)

Ergothioneine is associated with reduced mortality and decreased risk of cardiovascular disease
por: Smith, Einar, et al.
Publicado: (2020)

Cardiovascular disease and mortality sequelae of COVID-19 in the UK Biobank
por: Raisi-Estabragh, Zahra, et al.
Publicado: (2023)

Cardiovascular risk after hospitalisation for unexplained syncope and orthostatic hypotension
por: Yasa, Ekrem, et al.
Publicado: (2018)

The value of aspartate aminotransferase and alanine aminotransferase in cardiovascular disease risk assessment
por: Weng, Stephen F, et al.
Publicado: (2015)

Marginal role for 53 common genetic variants in cardiovascular disease prediction
por: Morris, Richard W, et al.
Publicado: (2016)

Association of occupational exposures with cardiovascular disease among US Hispanics/Latinos
por: Bulka, Catherine M, et al.
Publicado: (2019)

Association of Life's Simple 7 and presence of cardiovascular disease in general Australians
por: Peng, Yang, et al.
Publicado: (2017)

Systolic blood pressure, chronic obstructive pulmonary disease and cardiovascular risk
por: Rao, Shishir, et al.
Publicado: (2023)

Assessment of haemoglobin and serum markers of iron deficiency in people with cardiovascular disease
por: Graham, Fraser J, et al.
Publicado: (2023)

The importance of early life family factors in the association between cardiovascular risk factors and early cardiovascular mortality
por: Kjøllesdal, Marte K R, et al.
Publicado: (2017)

Change in cardiovascular risk assessment tool and updated Norwegian guidelines for cardiovascular disease in primary prevention increase the population proportion at risk: the Tromsø Study 2015–2016
por: Nilsen, Amalie, et al.
Publicado: (2021)

Systematic screening for cardiovascular risk at pharmacies
por: Rohla, Miklos, et al.
Publicado: (2016)

Angiotensin receptor blockers for prevention of cardiovascular disease: where does the evidence stand?
por: Fuchs, Flávio Danni, et al.
Publicado: (2015)

Associations between polymyalgia rheumatica and giant cell arteritis and 12 cardiovascular diseases
por: Pujades-Rodriguez, Mar, et al.
Publicado: (2016)

Sub-optimal cholesterol response to initiation of statins and future risk of cardiovascular disease
por: Akyea, Ralph Kwame, et al.
Publicado: (2019)

Outcomes of an integrated community-based nurse-led cardiovascular disease prevention programme
por: Connolly, S B, et al.
Publicado: (2017)

Sex differences in the association between childhood maltreatment and cardiovascular disease in the UK Biobank
por: Soares, Ana Luiza Gonçalves, et al.
Publicado: (2020)

Impact of COVID-19 pandemic on cardiovascular diseases hospitalisation, management and mortality in Switzerland
por: Maung, Ko Ko, et al.
Publicado: (2023)

Residual cardiovascular risk in individuals on lipid-lowering treatment: quantifying absolute and relative risk in the community
por: Lieb, Wolfgang, et al.
Publicado: (2018)

Association between treatment for erectile dysfunction and death or cardiovascular outcomes after myocardial infarction
por: Andersson, Daniel P, et al.
Publicado: (2017)

Systematic review of clinical guidelines for lipid lowering in the secondary prevention of cardiovascular disease events
por: Brown, Rosemary Elisabeth, et al.
Publicado: (2020)

Elevated cardiovascular disease risk in low-income women with a history of pregnancy loss
por: Tsulukidze, Maka, et al.
Publicado: (2022)

Low prevalence of ideal cardiovascular health in Peru
por: Benziger, Catherine P, et al.
Publicado: (2018)

COVID-19 and its impact on the cardiovascular system
por: Khawaja, Saud Ahmed, et al.
Publicado: (2021)

Lean body mass index prognostic value for cardiovascular events in patients with coronary artery disease
por: Hioki, Hirofumi, et al.
Publicado: (2015)

Mortality and high risk of major adverse events in patients with COVID-19 and history of cardiovascular disease
por: Tessitore, Elena, et al.
Publicado: (2021)

Machine learning approaches improve risk stratification for secondary cardiovascular disease prevention in multiethnic patients
por: Sarraju, Ashish, et al.
Publicado: (2021)

Cardiovascular consequences of discontinuing low-dose rivaroxaban in people with chronic coronary or peripheral artery disease
por: Dagenais, Gilles R, et al.
Publicado: (2021)

Cardiovascular disease risk factors in relation to smoking behaviour and history: a population-based cohort study
por: Keto, Jaana, et al.
Publicado: (2016)

Independent external validation of the QRISK3 cardiovascular disease risk prediction model using UK Biobank
por: Parsons, Ruth E, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_lnivg0g824n3q802dp12ec9ot3